1.
Goidescu IG, Caracostea G, Eniu DT, Stamatian FV. Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population. Med Pharm Rep [Internet]. 2018 Apr. 26 [cited 2025 Oct. 5];91(2):157-65. Available from: https://medpharmareports.com/index.php/mpr/article/view/894